Investigating the Application of Interpretability Techniques to Computational Toxicology by Banerjee, Aranya et al.
Abstract
Title: INVESTIGATING THE APPLICATION OF
INTERPRETABILITY TECHNIQUES TO
COMPUTATIONAL TOXICOLOGY
Aranya Banerjee, Kevin Boby, Samuel Lam, David
Polefrone, Robert San, Erika Schlunk, Sean Wynn,
Colin Yancey
Directed by: Dr. Soheil Feizi
Department of Computer Science, University of Maryland
A barrier to the incorporation of predictive models for drug design lies in their
lack of interpretability. To this end, we examine on three fronts the interpretabil-
ity of benchmark models for the 2014 Tox21 Data Challenge, an initiative in
the domain with a dataset of measurements across twelve toxicity experiments.
On existing measures of model performance, we assess the current benchmark
metrics’ ability to describe model behavior and recommend an alternative set
of metrics for the task. On the existing interpretability methods for machine
learning models, we quantitatively and qualitatively evaluate their application
to this domain by measuring desirable properties of explanations they produce.
Additionally, we incorporate a recently described method for partial charge pre-
diction as novel input for a toxicological model and observe its resulting model
performance and model interpretability.
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1 Introduction
Toxicology is a critically important scientific field, combining inno-
vations in biology, chemistry, and pharmacology. Toxicologists work in many
capacities, including in academics, industry, and regulatory agencies. They may
treat cases of poisoning in emergency departments, contribute to pharmaceuti-
cal research relating to drug safety, or advise health policy. They study a wide
range of chemical compounds that have effects on humans, animals, and the
environment. Since toxicology directly relates to the effects of these chemicals
on biological life, the primary method of study has been experimentation on
biological subjects and tissues. However, a developing area within toxicology,
drawing from the availability and power of computational resources, is compu-
tational toxicology. The origins of this discipline may be traced to the advent of
systematic toxicology investigations conduced by the Environmental Protection
Agency (EPA) in the mid-1980s, with a focus on potential exposure hazards of
consumer products and other chemicals [1].
Computational toxicology develops models that predict adverse health
effects that do not rely on in vivo and in vitro testing and their associated costs
[2]. While it does not have the capability of totally replacing these methods,
its application could potentially reduce costs, increase speed and efficiency, and
provide more ethical approaches to drug testing [3]. Pharmaceutical companies
already use computational methods to screen large numbers of compounds be-
fore developing the promising candidates further, already demonstrating some
of the powerful cost-saving capabilities of computers in today’s research [2].
Predictive models hold the potential to reduce the risk of toxic drugs entering
the market, in part by reducing wasteful investigations into drugs which might
turn out to be toxic later on in trials. One important area of application of
toxicology has not yet readily accepted the use of computational models: the
regulatory field.
1.1 Drug Approval
In the United States, the Food and Drug Administration (FDA) over-
sees the drug approval process. Bringing drugs to market with FDA approval
occurs in five broad steps. Step 1 involves Drug Discovery and Development,
which is the job of pharmaceutical chemists, biologists, and medical experts.
Step 2 involves Preclinical Research, which takes place in lab research settings
by industrial researchers, who may utilize in vivo and/or in vitro trials. Good
Laboratory Practices, as defined by FDA in 21 C.F.R. Part 58.1 [4], guide re-
search in this step.
Step 3 is Clinical Research, which is perhaps the most central in the
process. This step involves testing on human cohorts, and occurs in several
phases, with increased study sizes at each phase. Should a drug fail any phase,
it does not proceed on to subsequent phases. Industrial researchers may consult
the FDA for assistance in designing trials. In Phase 1, drugs are tested for
their safety and dosage. In Phase 2, drugs are tested for their efficacy and side
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effects. In Phase 3, drugs are tested for their efficacy, and monitored for adverse
reactions. In Phase 4, drugs are tested for their overall safety and efficacy.
If a drug passes each of these phases, it moves on to Step 4, or FDA
drug review. This step involves the submission of all previous data to FDA in
a New Drug Application (NDA). The reviewers then scrutinize the data for 6
to 10 months and may approve it given a favorable evaluation. Subsequently,
FDA and drug developers then work together on appropriate prescribing and
labeling. At this point, the drug may arrive at markets, but is not done with
the regulatory process. In Step 5, the FDA conducts post-market drug safety
monitoring. This step includes various methods of drug monitoring and re-
evaluating.
1.2 Issues with the Drug Approval Process
The FDA approval process, which is upheld as a global standard, has
several critical shortcomings. First, it operates on a slow timetable: the average
time for drugs to reach market from their first time of experimentation is 12
years [5]. Additionally, it is financially costly and risky. According to a landmark
study by the Tufts Center for the Study of Drug Development, the average total
cost to bring a drug to the pre-approval stage is $2.558 billion, in 2013 dollars
[6]. Not considering opportunity costs incurred by delays in the process, the
average out-of-pocket financial cost is $1.395 billion, in 2013 dollars [6]. The
levels of safety assurance it provides are also arguably not efficient, given the
lack of context dependence involved. Even if the statistical thresholds for testing
false positives and false negatives are appropriately slim on the aggregate, they
may not be appropriate as a dynamic standard from condition to condition.
In some life-or-death cases, false negatives may be much more life-threatening
than false positives. The converse applies to routine, low-level conditions, which
have small adverse effects across a large population, since there is then a larger
potential hazard promulgated across a much wider group of individuals [7].
Finally, and perhaps most notably, the process itself carries some de-
gree of danger. In 1993, five patients died in a Phase I trial of fialuridine,
a seemingly exciting new drug for the treatment of hepatitis B [8]. In 2006,
six patients experienced multi-organ failure in a Phase I trial of TGN1412, an
antibody intended to fight autoimmune disorders. Researchers had given the
antibody to subjects at a dose 500 times lower than that which was deemed
safe after animal trials [9]. This is not intended to be a completely pessimistic
viewpoint of FDA’s approval process, which is built under well-meaning princi-
ples and certainly improves the quality of care across the U.S. and worldwide.
Still, it is not uncommon for drugs to pass through the preliminary screenings
for a drug with empirical animal studies to get to large-scale human trials and
fail due to problems that could have been previously detected [10]. There is no
doubt that there is room for improvement in drug screening, especially given
that the process does not leverage some of the most exciting new innovations in
toxicology: computational methods.
Currently, there exist computational toxicology models which are be-
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coming increasingly useful in representing in vitro and in vivo studies [2]. How-
ever, these models remain excluded from the regulatory process for several rea-
sons. One reason is simply that the predictive performance of the models is
no better than the in vitro assays on which they are trained. Moreover, these
models are centered around specialized endpoints, while live trials have more
general outputs [3]. Perhaps the most critical reason which bars computational
methods from the regulatory space, though, is their lack of interpretability.
Computational methods, especially those that deal with machine learning, usu-
ally fail to justify their judgments through grounding in the underlying bio-
chemical properties. This concept of interpretability could be subdivided into
two categories, which we will refer to as “direct interpretability” and “high-
level interpretability.” Direct interpretability refers to contextualization within
biological, chemical, and physiological principles, while high-level interpretabil-
ity refers to explanations which are easily understood by users due to posited
relationships based on high correlations for structural features.
In navigating these obstacles, it is important to recognize that per-
formance can be improved only so much, especially given that computational
methods rely on imperfectly collected data from live trials. Thus, while it is
obviously critical to strive for strong performance compared to the field as it
stands, it is not our current criterion of contribution within the field. Addi-
tionally, when considering that the level of complexity for an integrated human
physiological model would be extraordinarily computationally expensive, among
other issues of implementation, we do not believe that there are many gainful
strides to be made with a more generalized system. We feel that the largest
innovations awaiting the field of computational toxicology most likely are with
regards to improving their interpretability. A proof-of-concept toward a compu-
tational model that can clearly explain the chemical mechanisms behind toxicity
would strongly contribute to the field by demonstrating the growing potential
of computational models to be used in drug regulation and screening.
With these components explained, we have enough information to give
our research question in full: how can a computational model for toxicity pre-
diction be developed with novel techniques to enhance interpretability, while
retaining high accuracy? In answering this question, we will first move to sur-
vey the relevant literature on computational toxicology in general, with a special
focus on interpretability metrics.
1.3 The Tox21 Challenge
Created by the FDA in 2014, the Tox21 Challenge brought together a
global community of data scientists to apply machine learning techniques as a
method for predicting drug toxicity. The Tox21 Challenge called on researchers
to use structural data of chemical compounds to predict their interactions with
biological systems, especially with regards to toxicity. These endpoints, pre-
sented below, are all in vitro and were the result of high-throughput assays.
The dataset contains SMILES string representations of about 8000 molecules
can be accessed through the DeepChem Python library.
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Figure 1: Summary of the Tox21 dataset [11].
Due to the content of the Tox21 Challenge dataset, containing the tox-
icity classifications of thousands of molecules, it was the crucial data source on
which the team based its investigations into toxicity prediction. Many other
researchers have contributed models to the challenge, which were also of im-
portance to the team in the area of model analysis. The below table provides
detail regarding the class splits for the various assays included in the dataset.
For each assay, class imbalances are clearly present such that the significant
majority of molecules are not toxic for a given indication. Molecules are con-
sidered toxic for a given assay with an activity score deemed to be sufficiently
high as to be conclusive, while considerations of no toxicity are usually reserved
for molecules with activity scores of zero. Scores were determined based on the
fit of the half-maximal activity concentration (AC50) to a logarithmic form. It
should be noted that there are a variety of different molecular classes within the
Tox21 dataset, ranging from small molecules to relatively large carbohydrate
molecules. The domain of applicability for models developed includes the whole
set, which notably preserves the inclusion of some salts.
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Endpoint Count # Not Toxic # Toxic % Toxic
NR-AR 7265 7024 241 3.32%
NR-AR-LBD 6758 6566 192 2.84%
NR-AhR 6549 5937 612 9.34%
NR-Aromatase 5821 5583 238 4.09%
NR-ER 6193 5563 630 10.17%
NR-ER-LBD 6955 6688 267 3.84%
NR-PPAR-gamma 6450 6301 149 2.31%
SR-ARE 5832 5067 765 13.12%
SR-ATAD5 7072 6860 212 3.00%
SR-HSE 6467 6172 295 4.56%
SR-MMP 5810 5072 738 12.70%
SR-p53 6774 6420 354 5.23%
Table 1: Distribution of toxic and nontoxic molecules present for each toxicity
endpoint in Tox21 Challenge.
1.4 DeepChem
DeepChem is a powerful open source framework for deep learning in
the field of chemistry. Made publicly available in 2017, DeepChem makes use of
Google TensorFlow to create neural networks for deep learning. It also makes
use of the RDKit Python framework for operations such as creating molecular
graphs out of SMILES string representations of molecules. Among the features
it offers include featurizations of SMILES strings, including ECFP (Extended-
Connectivity Fingerprints), Graph Convolutions, and Coulomb Matrices. These
were the primary descriptor sets considered due to their easy availability in the
DeepChem framework. Comparison models which were previously developed are
often based in this framework and thus pri descriptor sets. In addition to the
deep learning components of DeepChem, the framework also provides a large
amount of chemical datasets, comprising over 500,000 chemical compounds.
Much of the data that the team used was from the DeepChem-provided dataset,
along with the Tox21 challenge dataset mentioned previously.
1.5 MoleculeNet
One of the many challenges associated with trying to improve molec-
ular machine learning has been trying to determine whether new methods have
improved upon the efficacy of the old ones. MoleculeNet was created with the
intent of finally solving this problem. It establishes a standard benchmark that
can be used to properly compare any improvement caused by new algorithms
being tested. It does so by curating many public datasets and establishing eval-
uation metrics using them. It also offers open-source implementations of many
published learning algorithms, built off of the DeepChem open source library.
The features offered by the MoleculeNet project proved to be of great help to
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the team, as it was used to compare whether the team’s proposed methods
improved upon previously published and tested ones.
Part of MoleculeNet’s work was the developement of baseline models
of different architectures for example the deep learning methods described in
sections 2.1 on 9, 2.2 on 9, and 2.3 on 10. They optimized hyperparameters
such as numbers of layers and training times for multiple datasets including the
Tox21 challenge. As of the time of this paper’s writing, we have used the most
updated hyperparameters that they provide.
2 Literature Review
2.1 Deep Neural Networks
Deep Neural Networks (DNNs) are a machine learning technique that
are based on artificial neural networks with many layers consisting of a high
number of neurons. DNNs have been one of the more popular methods in the
machine learning community and have performed well on tasks such as speech
recognition, computer vision, and other artificial intelligence applications. The
goal of neural network learning is to create functions that map an input vector
to an output vector and adjust the network weights so that the input-output
mapping has a high predictive power on future data. The mapping is parame-
terized by weights that are optimized during a learning process. As opposed to
shallow networks which only contain one hidden learning layer and a few hid-
den neurons per layer, DNNs contain many hidden learning layers with many
neurons each. This layout contrasts with traditional artificial neural networks,
which only use a few neurons. Deep neural networks are an improvement upon
classical neural networks in that the number of input descriptors that could
be handled is greater. This change allows models to retain valuable predictive
information, thereby assisting the DNN in capturing all possible aspects of the
input vector [11]. Notably, a DNN approach proved to be the best-performing
model in the original Tox21 competition [11].
2.2 Graph Neural Networks
Graph Neural Networks are forms of machine learning techniques which
can operate on graphs. While there are many variants of this class of models,
they all follow a similar structure. They all have an encoder, which generates
node embeddings for a local neighborhood of nodes, a decoder, which translates
these embedding back into the graph format, and a similarity metric, which is
used to compare nodes in a graph [12].
The encoding step takes a node in a graph and compresses information
about it and its neighbors into a lower dimensional vector which ideally preserves
the properties of the original graph, and the decoder undoes this step. The size
of this neighborhood and the function used to aggregate nodes at each step is
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user defined. Optimizing the encoder function is achieved through training using
the similarity metric, since nodes which are similar in the graph must also have
similar embeddings. Once the encoder and decoder are trained from a training
set of graph representations, they can be applied to find either new relationships,
or edges, between different graphs, or to classify a node in a different graph,
depending on how the encoder is optimized.
These models have the advantage of being able to operate on multiple
domains of information. Graphs are an extremely versatile data structure, as
nodes and edges can represent various elements and their interactions. One
group was able to leverage this to predict polypharmacy side-effects using in-
formation about all the various drug-drug, drug-protein, and protein-protein
interactions, with a high degree of accuracy [13]. To achieve this level of accu-
racy, however, such information has to be available, therefore these models are
not so useful where data for new inputs is sparse. However, this is a problem
faced by any model using multiple domains of data. These models are also
potentially very interpretable, thanks to their decoder. If the task is predicting
edges, which represent interactions that are being predicted by the modeler,
then the physical interpretation of a prediction will be apparent based on the
kind of interaction predicted by the decoder.
2.3 Convolutional Neural Networks
Convolutional Neural Networks (CNNs) are machine learning tech-
niques that work by convolving (or using a preset function to layer, shrink, and
modify) their input and then sending it through a variety of different layers.
There are many different ways to arrange these layers, but the fundamentals re-
main the same from model to model. Each model will start with a convolution
layer, which will take a convolution kernel which assigns every pixel a pre-set
weight, traverse the input image pixel by pixel, and use the kernel to create a
new image based off of its weights. This first convolution layer primarily detects
the low-level features, namely curves and edges [14].
CNNs also use a pooling layer, whose purpose is to reduce the reso-
lution of the feature maps generated by the convolution layers. By reducing
the resolution of the output maps, the layer’s kernels are able to detect more
abstract features and improve the model’s overall sense of the image. The third
layer used is known as the fully-connected layer. Much like the layer’s name
would suggest, the fully-connected layer takes all of the neurons generated by
the previous layer, regardless of what type of layer it might be, and connects
them to all neurons of the current layer. In doing so, the model creates global
semantic information which helps it produce a more accurate output image.
The backpropagation algorithm is the standard algorithm for training
CNNs, which analyzes errors and loss previously generated and calculates new
weights for the different parameters accordingly. The biggest strength of a
CNN is its incredible ability to classify and label various images, which is a
capability that we could use in identifying various compounds and chemical
descriptors. Another strength is that the various layers of the CNN complement
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each other, which improves total accuracy of the model. With these strengths
come weaknesses, one of which is a CNN’s tendency to overfit. When a model
overfits, it essentially “memorizes” its training dataset and produces inaccurate
and poor results when the input data is different [15].
Recent research has worked towards generalizing CNNs to operate on
graphs. The classic CNN operates on Euclidean data with grid structures;
most commonly, images [16]. Grids can be considered a subset of graphs that
are lattice-shaped and more rigidly defined. Generalizing CNNs to operate on
all graphs, which can be non-Euclidean and more flexible in application for
data representation, is greatly applicable to the development of models based
on molecule representations, since a graph structure based on bonds between
atoms is an intuitive representation of a molecule.
2.4 Interpretability Methods
Motivation
Machine learning has dominated classification efforts in recent years,
but wielding the technology is a double-edged sword for regulatory purposes. In
terms of predictive power, machine learning is practically without peer, allowing
for unprecedented accuracy in classification of toxicological effects. However,
this predictive power comes at the expense of interpretability. Interpretability
is the ability of the model to explain how it identifies output classifications to
a human in an understandable way. Many of the strongest machine learning
methods are inherently “black box” mechanisms which produce output from
input in a way that cannot be fully understood. The black-box problem, a
fundamental one in machine learning not unique to toxicology, is of critical
importance in the field to clearly identify the relationships that govern chemical
activity. Without the ability to interpret these strong models, they cannot be
completely trusted by regulatory bodies.
In 2007, the Organization for Economic Co-operation and Development
released a since-revised comprehensive document governing the validation of
predictive models [17]. This document identifies five main principles for the
regulatory acceptance of predictive models. Accordingly, they should have: a
defined endpoint, an unambiguous algorithm, a defined domain of applicability,
appropriate measures of goodness of fit, robustness, and predictive power, and,
if possible, a mechanistic interpretation. While machine learning methods can
satisfy some of these requirements, there is a significant amount of work to be
done to improve interpretability. Effective methods for interpreting black-box
predictions will significantly advance drug development and regulation via an
increase in model trust, which will improve overall public health as well. For
this reason that we wish to center our research around novel techniques for the
interpretability of machine learning models.
The first solution towards interpretability is the simplest: use the sim-
plest model architectures. A subset of algorithms including logistic regression
and decision tree all satisfy some properties that make them inherently easy to
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understand. In a logistic regression model, there exists a monotone relationship
between each feature and the final prediction. That is, either the final output
only increases as a feature value increases, or the final output only decreases
as a feature value increases. In a decision tree model, the architecture explic-
itly singles out those features that account for the greatest variance in the final
output. Given the choice between models of similar performance, the simpler
architecture will yield the greater interpretability.
The difficulty in tackling the issue, however, lies in balancing the ten-
sion between predictive power and interpretability. Models of increasing predic-
tive power used deep learning approaches of increasing complexity. A human’s
ability to follow a classifier’s reasoning required some degree of simplicity. The
solution lied in model-agnostic interpretability methods, methods that produced
explanations of model behavior post prediction without any requirements on the
classifier’s underlying architecture. Additionally, in some contexts, descriptors
which appear often in various models are examined with regard to biological
interpretation regardless of architecture. This expert rationale may form an
import component of interpretability.
Local Interpretability Methods
One solution is local interpretability methods, which tend to be model-
agnostic, meaning they require no specific model architecture. Rather than
deriving an interpretable function to explain the entire model, such as the co-
efficients in a logistic regression model that are relevant to the entire dataset,
an alternative approach to interpretability is to explain individual inputs to the
model instead. A highly nonlinear, complex decision boundary is more likely to
appear smoooth and linear when localized to a certain region.
This is the intuition behind LIME, a major breakthrough in local in-
terpretability methods [18]. For a given input x to a model f , this algorithm
attempts to return an explanation, an interpretable function g, which satisfies
two conditions: it is simple, and it is locally faithful. These two conditions are
required to obtain a good explanation for an input. Locally faithful means that
the behavior of g must correspond to the behavior of f in x’s vicinity. Clearly,
for g to provide any insight at all into why the model outputs f(x), it must
be a function which behaves like f , at least in the vicinity of x. Complexity is
a condition because not all interpretable functions are made equally. A linear
function with thousands of variables is not as comprehensible as one with five,
and the second would be preferred if it does not sacrifice too much local fidelity.
The optimal function g, which LIME derives, is therefore the function which
finds a balance between maximizing faithfulness and minimizing the complexity
of the function.
This algorithm provides its users with a direct insight into the internal
workings of the model, which bolsters confidence in predictions and opens the
door to mechanistic interpretations, which are a must for regulatory compliance.
By examining the relationship of the weights in the function returned by LIME,
a user can derive a mechanistic interpretation by translating the weights to the
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real chemical features they correspond to. While determining the validity of the
relationship expressed by this function does require expert knowledge, this is
far better than accepting the output on blind faith.
Offshoots of this work continued developing the concept of local in-
terpretability. Instead of forming a local surrogate model, Lundberg and Lee
used game theory to treat features as players and determines their contributions
towards the final prediction [19]. In ”Anchors: High-Precision Model-Agnostic
Explanations”, the original authors of LIME propose Anchors, an algorithm
that uses reinforcement learning and graph search learning to identify decisions
rules unaffected by changes in other features [20]. The authors demonstrated its
ability to aid users in predicting its classifications of unseen data in comparison
with linear-based interpretability methods. It shares a reliance with the original
LIME paper on observing changes in model behavior based on perturbations to
data.
The papers listed above yield high fidelity explanations for model be-
havior on instances of data, and their strength lies in their model agnosticism.
This includes models ranging from decision trees to convolutional neural net-
works. However, implementations of such work are scare for models that handle
some of the complex data representations associated with chemical data. That
is, little work exists for the interpretation of models handling molecular graphs.
Graph Convolutional Neural Network Interpretablity Methods
Pope and colleagues produced one major effort that generalizes exist-
ing interpretability methods for convolutional neural networks to graph convo-
lutional neural networks [21]. After all, image data handled by regular convo-
lutional networks are really instances of lattice-shaped graphs. Their methods
create heat maps over the nodes of graphs using five methods including gradient-
based methods, class activation mappings, and excitation backpropogation. Fi-
nally the paper evaluates its explanations by fidelity, contrastivity, and sparsity,
three interpretability metrics defined respectively as the loss in accuracy suf-
fered by the removal of features, the distance between explanations of opposite
classes, and the ratio between the number of nodes in a graph highlighted for
all output class to the number of nodes in the entire graph.
By incorporating these techniques, described in the context of gen-
eral ML as well as to some extent in toxicology literature, we extend the work
of methods previously applied to the Tox21 initiative for increased impact.
Namely, we focus on LIME for models based on molecular fingerprints [18]
and on Pope et al.’s work for models based on molecular graphs [21].
2.5 Model Accuracy Parameters
The most important metric to measure when developing machine learn-
ing models is accuracy. If a model is particularly inaccurate, then there is no
utility associated with it, as there is no confidence in the results that it outputs.
The primary measure of accuracy is the number of correct identifications divided
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by the total number of data points in the test set. This is acceptable for most
machine learning models, but in some cases, it is possible to have high accuracy
by this metric and still have a bad model. This can occur if the representation
of a positive and negative model is vastly unequal. Unequal distribution of the
classes in the training set can lead to the model training in such a way that max-
imizes accuracy by treating every input as either positive or negative regardless
of the input’s characteristics. If a model is trained on data where 90% of the
data points are in the positive class, then the model can achieve 90% accuracy
by classifying everything as positive. The problem is that the negative class is
identified incorrectly 100% of the time.
Additional accuracy metrics that can be used are the ROC curve (re-
ceiver operating characteristic curve) and the AUC (Area under the ROC curve).
The ROC curve is a curve that shows the true positive rate (x-axis) versus the
false positive rate (y-axis) for the model being tested. In the above example, the
false positive rate is 100%, and the true positive rate is 90%, meaning that the
point on the ROC curve is (1,1). The model is manipulated to perform with dif-
fering true positive rates, and the false positive rate is measured, and the curve
is generated. Once the curve is generated, then the AUC is found. An AUC
of 1 is defined as being a perfect model, and an AUC of 0 shows a model that
classifies everything incorrectly. The goal of the model is to approach an AUC
of 1; as it gets closer, the number of false positive rate will be shown to be lower
for various class distributions. Balanced accuracy, the average of sensitivity and
specificity, can serve as another option for addressing model performance.
2.6 Molecular Representation
Though molecules are commonly drawn as two-dimensional structures,
collections of letters and lines, they are in fact three-dimensional assemblies
of atoms which are always in motion. The vibrations of molecules may be
approximately calculated using computational chemistry techniques. However,
in considering how to ”draw” molecules for the use of a computer program, it
is not always useful or desirable to fully describe a molecule in the context of
its wavefunctions or quantum effects.
For many cheminformatics applications, small molecules are repre-
sented via SMILES (simplified molecular-input line-entry system) strings. In-
vented in the 1980s by Dave Weininger, the flexible and compact formatting
of SMILES strings have made them ubiquitous in chemical databases (¿2000
citations on the original paper as of the time of writing). Notably, SMILES re-
lies on a graph-theory approach to segmenting molecules into their component
branches before assigning sets of symbols to each branch. Despite their mer-
its and common usage, SMILES strings may be unwieldy due to their lack of
mandatory stereochemical information as well as imprecision in SMILES syntax
[22]. A variety of different strings may be used to represent the same molecule,
particularly for ring-containing systems. Additionally, it is difficult to ensure
that SMILES strings refer to valid molecules at all without checking them. This
is to say that the space of all possible SMILES strings is composed of many non-
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molecules [23].
As such, there have been many iterations of improvements on the
SMILES formatting to correct against these issues. Efforts have been made
by various groups of chemists to canonicalize SMILES strings, such as those
of Daylight Chemical Information Systems (founded by Weininger himself) [24]
and of OpenEye. The Daylight algorithm is commonly implemented since it was
written by Weininger, but does not incorporate a way to handle stereochemistry.
OpenEye’s algorithm is of note since it is used by many governmental agencies,
such as NIH, for the handling of their chemical databases. However, none of
these canonical algorithms has been established as a standard, and it is gener-
ally necessary to convert SMILES strings of unknown origin to a canonical form
using a given software package, even though it may not match up with other
databases effectively. There have additionally been attempts to universalize
chemical line-entry data apart from SMILES. The InChI (”International Chem-
istry Identifier”) format was developed by the International Union of Pure and
Applied Chemists (IUPAC) in the mid-2000s as a standard for computational
nomenclature. However, they are not always easy to use for computational
purposes, and as such are generally limited to molecular identifiers. Unlike
SMILES, there does exist a standard, open source algorithm for the generation
of InChI representations [25]. Fortunately, there have been relatively successful
efforts described to interchange between InChI and SMILES [25].
As explained at the outset of this section, real molecules are not static
objects. However, they do lend themselves rather nicely to being represented in
graph formats. After all, atoms may be thought of as the nodes in an undirected
graph, with various types of edges corresponding to various types of bonds [26].
It is easy to conceptualize this in two dimensions, and the extension to three
dimensions is not much more difficult. From here, though, it is usually necessary
to transform such graphs into arrays for computer readability [26]. (While there
are salient questions of image recognition for molecular visualizations, those
will be considered at a later point.) This transformation requires algorithms
which can map atoms to a given order, with edges defined in between them
based on the bond order of the molecule itself [26]. A corollary to this, which
often complicates the processing of molecules, is that these arrays are order-
dependent even though the originating graphs are not [26]. While these are
useful properties, graphs generally fail to capture more complex bonding types
(i.e. three-center bonds) and may be memory-inefficient [26].
There are also methods by which to encode chemical information based
on non-atomic information, known as molecular descriptors [27]. Otherwise
known as molecular fingerprints, these representations encode structures based
on the presence or absence of specific functional groups. There are, though,
many different types of fingerprints which account for molecular structures in
a variety of ways. A popular format, the Extended Connectivity Fingerprint
(ECFP), are circular in nature and are quick to calculate by using the Morgan
algorithm as a standard for operating [28]. The primary application for such
fingerprints is in structure-activity relationships (SARs) which use a group of
structurally related molecules [28], enabling ECFPs to exhibit greater utility
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than they might across a grouping of unrelated molecules [29]. Fingerprints
may also cover chemotypes (highly structurally similar classes of drugs) as a
simplifying technique to cover the chemical space which arises most often in
practical usage. Using molecular fingerprints to track similarity, Drwal and
colleagues described the implementation of a naive Bayes classifier approach
successfully to learn on the Tox21 dataset [30].
3 MoleculeNet Metric Comparison
3.1 Background
Area Under the Curve (AUC) is a metric that is commonly used to
benchmark prediction models where the curve is typically a Receiver Operat-
ing Characteristic (ROC) curve [31]. The ROC curve plots the true positive
rate against the false positive rate at a variety of classification thresholds, so
a classifier with an AUC-ROC of 1 would be ideal. AUC-ROC is the metric
MoleculeNet [32] used to compare different classifiers for Tox21 as suggested
by [33]. AUC-ROC is agnostic to class imbalances [34], which is a property of
Tox21. In Tox21 there are many more non-toxic (negative class) compounds
than there are toxic (positive class) compounds. As a result of an unbalanced
data distribution, classifiers built on Tox21 can be less sensitive to the toxic
class which can cause a higher rate of false negatives in the classification [34].
In the practice of toxicology, false negatives are especially dangerous as it is
the case where a compound is in fact toxic but is not identified as such. Since
AUC-ROC is not dependant on a balanced dataset, it is a justified metric to
compare prediction models; however, the metric is negligent to the importance
of sensitivity in toxicity prediction.
A component of improving a model’s interpretability is studying how
to report the model’s performance completely. Performance metrics we con-
sidered were area under the curve (AUC), accuracy, sensitivity, and specificity.
We collected performance metrics for the models we explained and observed
that each metric gave a different impression of performance compared to the
AUC-ROC. For further investigation, we collected the four metrics on every
Tox21 model in MoleculeNet [32] and again observed a significant variation for
each metric between models. This experiment reveals that AUC-ROC does not
predict other metrics for Tox21, and comparisons of model performances would
benefit with the inclusion of other measures.
Accuracy is the measure of the model’s ability to correctly identify
toxic compounds as toxic and non-toxic compounds as non-toxic.
Accuracy =
true positives + true negatives
total predictions
(1)
Class specific accuracy separates the classes in order to calculate the accuracy.
Sensitivity is the positive class accuracy, how well the model can identify a
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AUC-ROC vs Sens. AUC-ROC vs Spec. AUC-ROC vs Acc.
0.3304 0.2374 0.1625
Table 2: P-values for AUC-ROC againt sensitivity, AUC-ROC against speci-
ficity, and AUC-ROC vs Accuracy for the Tox21 Benchmark models.
compound as toxic. Specificity, on the other hand, is the negative class accuracy,
how well the model can identify compounds as non toxic.
Sensitivity =
true positives




true negatives + false positives
(3)
3.2 Metric Comparison Method
As MoleculeNet [32] utilized the open source package DeepChem [35],
we used this software to recreate the Tox21 models benchmarked in MoleculeNet
[32]. Although the architectures were provided in DeepChem [35], the code in
MoleculeNet [32] is not available, and so the AUC-ROC values displayed in
Figure 1 are slightly lower than those in MoleculeNet [32]. We then applied
the evaluation method to the models we operated on, graph convolutional net-
work and multitask classifier, to collect AUC-ROC, accuracy, sensitivity and
specificity.
3.3 Discussion
In this section, we report our observations from the metric comparison
experiment.
Figure 2 illustrates how models with comparable AUC-ROC can have
relatively large, inconsistent differences in other metrics. The models are or-
ganized left to right in ascending order by AUC-ROC, yet the other metrics
do not follow this trend. For example, models with higher AUC-ROC do not
necessarily have higher sensitivity. Another observation is the relative score of
metrics differ between models arbitrarily, for example, accuracy is not always
greater than AUC-ROC and the size of this discrepency is not the same between
the models. Table 1 quantifies the lack of correlation between AUC-ROC and
other metrics with P-values that are not statistically significant for p < 0.5.
From these results we realize there is an unpredictable difference within
a model’s accuracy and class specific accuracy relative to AUC-ROC, addition-
ally the magnitude and direction of the difference between metrics is not implied
by AUC-ROC. It is important to know the other metrics in isolation because







































































Figure 2: Comparison of performance metrics for Tox21 Models included in
MoleculeNet.
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AUC-ROC is a meaningful metric to measure the performance of a
Tox21 prediction model, but it is not complete by itself. Due to the substan-
tial and unpredictable variation of a model’s metrics we recommend including
accuracy, sensitivity, and specificity to supplement AUC-ROC when reporting
metrics.
4 Evaluation of Model Explainers
4.1 Background
Expanding on [21] described in the literature review, evaluations were
conducted on the fidelity, contrastivity, and sparsity of the explanations. Recall
that fidelity is the difference between the model’s performance before occluding
influential features as determined by the explainer, and after occluding these
features. The features with weights greater than a certain threshold are selected
to be removed. A strong explainer is expected to have a high fidelity score,
as this means that the explainer is correctly identifying the key features that
the model recognizes as important to its classification decisions. Contrastivity
is measuring the uniqueness of features identified for the different classes the
model can assign. A high contrastivity is a property of a strong explainer
because it demonstrates the ability of the explainer to create a clear set of
features responsible for the specific classifications of the model. Sparsity is a
ratio of the number of relevant features as determined by the explainer to the
total number of features, a useful metric to monitor.
4.2 Explainer Methodology
To create these metrics, the methodology used was adapted from the
approach mentioned in [21].
One major adjustment to this methodology was the modification to
fidelity as a difference in accuracies before and after the model has features
occluded. The motivation for this was due to preliminary results where occlu-
sion of features noted as relevant by the explainer either maintained the same
accuracy or even improved the accuracy of the model. This seemingly contra-
dicted what would be expected from feature occlusion, but was suspected to
be a result of an unbalanced dataset. As shown in section 1.3 on page 6, the
dataset is dominated by non-toxic class samples, so the model may be prone
to predicting a non-toxic over a toxic classification, which would result in this
unusual accuracy behavior. Observing this, we adjust the definition of fidelity
to be the difference of AUC-ROC before and after the occlusion of features. We
extended the study of [21] by applying the evaluation metrics to all 12 tasks of
Tox21.
We also made adjustments when extending these evaluation metrics to




CAM-GradCAM 1±0.000151 0.929±0.0124 0.15±0.079
EB 0.444±0.0486 0.675±0.0561 0.21±0.0604
GradCAM-avg 0.487±0.0475 1±4.32e-05 0.208±0.066
Gradient 0.0139±0.0031 0.992±0.00249 0.438±0.0647
cEB 0.912±0.021 0.751±0.0422 0.172±0.0997
LIME 0.108±.0558 0.0780±0.0461 0.0
Table 3: Evaluation metrics for Tox21 for all graph explainers and LIME. Fi-
delity was calculated using a threshold of 0.05.
We realized that LIME produced a different distribution of values to quantify
the importance of certain features and performed experiments which impacts
the calculation of fidelity. To address this we included a LIME fidelity calculated
at a lower threshold.
4.3 Discussion
Figure 3 on page 21 displays the results of the preliminary experiments,
the mean and standard deviation of fidelity across 12 tasks calculated using
accuracy. The substantial variation in fidelity, even taking on negative values,
prompted the investigation into using AUC-ROC to calculate fidelity.
Figure 4 on page 22 presents the mean and standard deviation of fi-
delity calculated using AUC-ROC. Comparing Figure 4 to Figure 3 suggests
that AUC-ROC is a more stable way of calculating fidelity for Tox21.
The contents of table 3 on page 20 display the mean explainers eval-
uation metrics for the 12 tasks for each graph method and LIME. The fidelity
for LIME is 0.0 because at the threshold used to occlude features was too great
for the values LIME set, and so no features were excluded. This is because the
applicability domain was kept open to all molecules within the Tox21 dataset.
5 Electrostatic Potential Model
5.1 Background
An important facet of our research is the development of a model
that takes in a novel input format. Normally, it is assumed that the structure
of a molecule is important in predicting its toxicity. Certain arrangements of
atoms and features are often noted as contributing to toxicity. In our model,
we decided to include additional information for molecule representations in
















Figure 3: Fidelity, or loss in model performance due to removal of features
highlighted by interpretability methods, averaged over Tox21 dataset. Error















Figure 4: Model interpretability metrics averaged over Tox21 dataset. Fidelity
is redefined as loss in AUC-ROC rather than loss in accuracy. Error bars are
standard deviations. Colors correspond to interpretability methods.
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We expected that accurate charge-based data would serve as an im-
provement to current models based on the commonplace use of simple two- or
three-dimensional structures fed into models. This was desired as opposed to
Gasteiger charges or other straightforward partial charge models in part due to
accuracy, as well as the potential novelty of a simplified workflow that would
ideally approximate the improved resolution of DFT-based charge prediction
while avoiding its computational expense. The way molecules influence bio-
logical systems in part depends on molecule dynamics, and could be useful in
toxicity predictions. Thus, developing a representation for molecules’ ESP fields
to be used as an input for our own model is a novel direction in computational
toxicology.
5.2 Dataset Construction
The initial data used by models in the Tox21 challenge were recovered
in SMILES form from the deepchem library [35]. These were transformed into
a multi-molecule .sdf file using the CACTUS service provided by the National
Institutes of Health. There were minor errors at this step (9 molecules out of
7831) for molecules containing macrocycles and/or bridged cycles. Structures
for these 9 molecules were manually recovered using PubChem’s structural sim-
ilarity search function. Using the OpenBabel package, this file was split into
individual molecular files (.mol file extension as an output from this step).
In order to obtain inputs in the correct form, as PQR files, the SMILES
strings from the Tox21 database went through a multi-step conversion process.
First, they were converted into canonical SMILES form, specified by InChI.
These could be used to retrieve chemical IDs and SDF files from the PubChem
database. OpenBabel [36] was used to convert the SDF files into MOL files.
From here, the ESP-DNN package [37] was used to generate partial charge data
for the molecules (n=7831) in the dataset. ESP-DNN is notable since it is a
computationally inexpensive method which has been shown to yield electrostatic
potentials at a comparable level to density functional theory (DFT) [37]. While
we initially considered the use of DFT methods for the generation of quantum
chemical data [38], we decided against this largely due to constraints on com-
putational resources available. As such, we sought to use it for our purposes as
an efficient method for predicting partial charges on given atoms. At the time
of writing, it appears that this method has not previously been used for the
development of any computational toxicology model.
ESP-DNN was used to convert the MOL files into the PQR files that
can then be used to predict point charge densities. In total, 5308 molecules were
in the dataset at this step, due to errors in conversion processes and queries re-
moving several molecules. Using OpenBabel, these PQRs were reconverted to
PDB files. Importantly, the reconversion was performed using the AssignBon-
dOrdersFromTemplate command in OpenBabel with the original MOL files as
templates, which was necessary since the PQR files themselves did not retain
appropriate bonding information, particularly for aromatic groups.
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5.3 Hypothesis Testing
In order to test our hypothesis that the addition of ESP fields would
improve model interpretability without comprising model performance, we per-
formed a comparison of two otherwise identical models, one model with the
ESP fields and one model without. Due to the computational cost of the in-
terpretability methods for molecular fingerprints combined with the lesser pre-
dictive power and interpretability of models that use them, we restricted our
analysis to the molecular graph data representation. We added ESP fields to
the molecular graph representations by appending the partial charges for each
atom in a molecule to the molecule’s feature matrix.
Working with molecular graphs with and without ESP fields, we se-
lected the same model architecture and hyperparameters from [21] for their
favorable balance of high model performance with high model interpretability
shown in section 4 on page 19. Based on our recommendations from section ??
on ??, we measured model performance using AUC-ROC, accuracy, sensitivity,
and speficity. We use the same methodology for model interpretability from 4
on page 19, using the interpretrabity methods and intepretability metrics from
[21], but redefining fidelity as a loss in AUC-ROC rather than a loss in accuracy.
For both models we used the same subset of molecules from the Tox21 dataset
for which we could recover ESP fields in section 5.2, which we refer to as the
Tox21 ESP dataset.
After collecting model performance and intepretability metrics for the
two models and aggregating them over the Tox21 ESP dataset, we performed
two-sample t-tests to determine the statistical significance of their differences.
Accuracy AUC-ROC Sensitivity Specificity
Dataset
Training 8.3e-31 5.02e-56 2.05e-20 1.27e-27
Validation 8.1e-30 3.44e-39 1.45e-16 1.64e-26
Test 2.83e-30 8.75e-47 7.21e-19 1.62e-27
Table 4: P-values of two-sample t-tests comparing model performance of graph
convolutional models with and without ESP data averaged over Tox21 ESP
dataset
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Figure 5: Change in model performance metrics of graph convolutional models
due to addition of ESP data averaged over the Tox21 ESP dataset. Error bars













Figure 6: Change in interpretability metrics of graph convolutional models due
to addition of ESP data averaged over Tox21 ESP dataset. Error bars are




CAM-GradCAM 9.84e-14 5.74e-07 0.398
EB 0.0532 0.00967 0.417
GradCAM-avg 0.502 0.39 0.0244
Gradient 1.08e-10 3.03e-09 0.000269
cEB 0.972 0.204 0.152
Table 5: P-values of two-sample t-tests comparing interpretability of graph
convolutional models with and without ESP data averaged over Tox21 ESP
dataset
5.4 Discussion
Figure 5 on page 25 shows that the addition of ESP fields reduced
predictive power, and table 4 on page 24 shows that the differences were of sta-
tistical significance. Figure 6 on page 26 in combination with table 5 shows that
the addition of ESP fields produced negligible change in interpretability metrics,
with few significant results and none indicating a significant improvement for
any of the graph-based interpretability methods.
Figure 5 on page 25 shows the difference in model performance between
the model with ESP fields and the model without. The addition of ESP fields
reduced model performance in training, validation, and testing on all metrics,
and table 4 on page 24 shows that the losses were of statistical significance.
Thus, the new data did compromise model performance of the graph convolu-
tional neural network. However, its performance remained comparable to that
of lower performing models mentioned in our evaluation of model performances
in section 3.
Pressing onto interpretability, figure 6 on page 26 shows the difference
in model interpretability between the model with ESP fields and the model
without. The addition of ESP fields produced no significant improvement in
fidelity, contrastivity, and sparsity for the explanations produced by each of the
graph intepretability methods. Table 5 on page 27 shows that the few changes
in interpretability metrics that were positive could likely be due to chance.
We believe that this impaired performance was in part due to errors
in the estimation of the partial charges in our methodology. Based on a review
of the input structures from the Tox21 ESP dataset, the geometries of the
input structures appeared to be somewhat distorted (i.e. slight errors in bond
angles). While intuitively it seems likely that the model would account for
small deviations such as these, it may be the case that they factored more
heavily than expected into the processing of the data. Future investigations
should further consider the implementation of this or related ML-based charge
prediction methods for the basis of generating augmented datasets.
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6 Conclusion
Computational toxicology is an important field which will enjoy future
growth, both in industry and academia, given the recognized need for better
screening process in tandem with improvements in data analysis techniques. The
drug trial process is often times long, expensive, and potentially dangerous for
those that participate as subjects. Computational toxicology seeks to reduce the
necessity of live drug trials by ruling out certain drugs based on their similarity
to known toxic molecules. Our model will be built using past drug trials and
results as training data, so that we can predict whether unexamined molecules
will be toxic or not. Since the quality of our model is built on these previously
conducted in vivo and in vitro trials, it is crucial that we are able to select and
use high-quality data.
The ultimate goal of this project has been to create a model which
can both make accurate predictions regarding toxicity within the human body
and clearly explains the predictions it makes. Current computational models
represent the toxicity of untested drugs fairly accurately, but we attempt to
maintain these levels of accuracy in our model while avoiding the black-box
paradigms of these existing models by incorporating features which provide
context and interpretability for its decisions.
It was found that in addition to the overall model accuracy, the AUC-
ROC was found to be a meaningful metric to be used within the realm of com-
putational toxicology. The AUC-ROC is important as it identifies the model’s
tendency to have false positives in its predictions. However, AUC-ROC is not
the only useful metric. Overall accuracy, sensitivity, and specificity are all also
recommended for model assessment.
From the models that were developed, we found that the interpretabil-
ity results provided by LIME for a bitstring model were significantly worse than
the results given by the graph convolution network explainer. This is to some
extent to be expected, as the input representation that LIME was attempting
to interpret was imperfect, and could not be traced back to specific instances of
present atoms in molecules, whereas the graph convolution network was able to
identify each of the atoms in the molecule and rank their respective importance
to the toxicity prediction. This resulted in the graph convolution explainer
having significantly higher performance in fidelity and other interpretability
metrics.
The other method that attempted to improve the interpretability of
the models was to provide electrostatic potential information as the input for a
model. The electrostatic potentials of each molecule in the dataset were calcu-
lated through a pipeline starting with the SMILES string of the molecule and
ending with an approximation of static 3D charge distribution. It was thought
that giving information on electrostatic potentials would give some information
regarding the molecule dynamics within a biological system. However, it was
found that adding the electrostatic potentials of each of the molecules severely
harmed the accuracy and fidelity of the model. Further optimization of the data
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pipeline may aid the performance of the model.
We remain confident that it is feasible to construct a models using
identified methods for interpretability which have not yet been tested in the
computational toxicology space. We were able to compare the utility of both
LIME and the graph convolution network explainer on the toxicology models,
but further optimization of explanations of toxicological models is necessary to
establish further trust in the models’ predictions.
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[23] Mario Krenn, Florian Häse, AkshatKumar Nigam, et al. “Self-referencing
embedded strings (SELFIES): A 100% robust molecular string representa-
tion”. en. In: Machine Learning: Science and Technology 1.4 (Nov. 2020).
Publisher: IOP Publishing, p. 045024. issn: 2632-2153. doi: 10.1088/
2632- 2153/aba947. url: https://doi.org/10.1088/2632- 2153/
aba947 (visited on 03/31/2021).
[24] David Weininger, Arthur Weininger, and Joseph L. Weininger. “SMILES.
2. Algorithm for generation of unique SMILES notation”. In: Journal of
Chemical Information and Computer Sciences 29.2 (May 1989). Publisher:
American Chemical Society, pp. 97–101. issn: 0095-2338. doi: 10.1021/
ci00062a008. url: https://doi.org/10.1021/ci00062a008 (visited on
03/31/2021).
[25] Noel M. O’Boyle. “Towards a Universal SMILES representation - A stan-
dard method to generate canonical SMILES based on the InChI”. In:
Journal of Cheminformatics 4.1 (Sept. 2012), p. 22. issn: 1758-2946. doi:
10.1186/1758-2946-4-22. url: https://doi.org/10.1186/1758-
2946-4-22 (visited on 03/31/2021).
[26] Laurianne David, Amol Thakkar, Roćıo Mercado, et al. “Molecular rep-
resentations in AI-driven drug discovery: a review and practical guide”.
In: Journal of Cheminformatics 12.1 (Sept. 2020), p. 56. issn: 1758-2946.
doi: 10.1186/s13321-020-00460-5. url: https://doi.org/10.1186/
s13321-020-00460-5 (visited on 03/31/2021).
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8 Appendix A: Nomenclature
Terms/Abbreviations Definitions
Black Box A function that returns outputs
given inputs without knowledge of
its implementation.
Data Curation Involves collecting and processing
data: aggregating relevant data
from a data set, removing duplicates
and problematic chemical forms
whose descriptors cannot be
calculated.
Decision Tree A tree-like model of decisions and
consequences. Represents an
algorithm that tests selected
attributes to be classified.
Model Validation Evaluation of model performance
and deriving various metrics which
will allow for comparison of the
performance of the model.
Molecular Descriptor An encoding of chemical information
for mathematical treatment.
Multitask Learning An approach to machine learning in
which multiple tasks are learned




Classification model based on
chemical structural similarities.




Analogous to a QSAR; relates
structure to a chemical property.
Random Forest A machine learning method using
many decision trees as base learners
in an ensemble.
Structural Alert Chemical substructure associated
with a toxicity endpoint.
Toxicity Endpoint Adverse physicochemical or
biological effect defined with
experimental conditions and
protocols.
Training Set Data set used as input for a model
in the development process.
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Classification Model A model that has a finite number of
discrete output states, called classes.
Validation Set Data set used as input for a model
to analyze its effectiveness. The
results from the model’s output are
compared against experimental
values.
Machine Learning Methods Algorithms which converge to a
model of the data by learning from
a training set.
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